ML390
CAS No. 2029049-79-2
ML390( —— )
Catalog No. M22425 CAS No. 2029049-79-2
ML390 exerts its potent differentiation effect on multiple leukemia models.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 39 | In Stock |
|
| 25MG | 69 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 188 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML390
-
NoteResearch use only, not for human use.
-
Brief DescriptionML390 exerts its potent differentiation effect on multiple leukemia models.
-
DescriptionML390 exerts its potent differentiation effect on multiple leukemia models.
-
In VitroML390 is active with an ED50 of ~2 μM in murine and human AML cell lines. In vitro, treatment of Lys-GFP-ER-HoxA9 cells with ML390 for 48 hr inhibits DHODH activity, leading to the dramatic (>500-fold) accumulation of the upstream metabolite DHO and the depletion of uridine and other downstream metabolites.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2029049-79-2
-
Formula Weight406.4
-
Molecular FormulaC21H21F3N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:27 mg/mL (66.44 mM)
-
SMILESFC(F)(F)Oc1ccc(cc1)C(=O)NCCC(=O)N[C@@H]1CCCc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sykes DB et al. Discovering Small Molecules that Overcome Differentiation Arrest in Acute Myeloid Leukemia. National Center for Biotechnology Information (US); 2010-2013 Dec 15.
molnova catalog
related products
-
Anemarrhenasaponin I...
Anemarrhenasaponin Ia, an useful anti-inflammation reagent, is isolated from Anemarrhenae rhizome. Anemarrhenasaponin Ia inhibits the generation of N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide.
-
ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
-
Daphnoretin
Daphnoretin has anticancer effects on leukemia, osteosarcoma and uterine cervix cancer cells, might through promoting apoptosis in a mitochondria-mediated way.
Cart
sales@molnova.com